• Topics

  • Formats

Organiser: Pronovea

TOPIC HIGHLIGHTS

  • Addressing inconsistencies in regulatory frameworks across different EU regions and improving global collaboration.
  • Exploring the role of AI/ML in predicting adverse events and improving pharmacovigilance processes.
  • Enhancing the collection of real-world data to monitor the long-term safety of medications after they reach the market.
  • Improving Signal Detection through Big Data and Advanced Analytics: Leveraging large datasets and analytics to enhance the detection and evaluation of safety signals.
  • Effective communication of drug safety risks to healthcare professionals, patients, and the public.
  • Protecting sensitive data in drug safety systems, particularly as digital tools and cloud technologies become more prevalent.
  • Addressing the Rise of Counterfeit Drugs in Global Markets: Strategies for improving drug traceability and combatting counterfeit medicines that pose significant safety risks.
  • Ecopharmacovigilance: Reducing environmental impact and enhancing patient safety by integrating eco-pharmacovigilance practices.
  • Enhancing pharmacovigilance systems across the EU to ensure real-time monitoring and reporting of adverse drug reactions (ADRs)
  • Overcoming the Challenges in Implementing and Optimizing EudraVigilance for Drug Safety in the EU
Available Dates

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?